PT1156814E - Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre - Google Patents

Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre

Info

Publication number
PT1156814E
PT1156814E PT00907455T PT00907455T PT1156814E PT 1156814 E PT1156814 E PT 1156814E PT 00907455 T PT00907455 T PT 00907455T PT 00907455 T PT00907455 T PT 00907455T PT 1156814 E PT1156814 E PT 1156814E
Authority
PT
Portugal
Prior art keywords
cosmetic compositions
comprehensing
ginger
fatty acid
pharmaceutical compounds
Prior art date
Application number
PT00907455T
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Eurovita A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurovita A S filed Critical Eurovita A S
Publication of PT1156814E publication Critical patent/PT1156814E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT00907455T 1999-03-03 2000-03-02 Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre PT1156814E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199900293 1999-03-03

Publications (1)

Publication Number Publication Date
PT1156814E true PT1156814E (pt) 2004-01-30

Family

ID=8091922

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00907455T PT1156814E (pt) 1999-03-03 2000-03-02 Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre

Country Status (11)

Country Link
US (2) US6482421B2 (pt)
EP (1) EP1156814B1 (pt)
AT (1) ATE249231T1 (pt)
AU (1) AU2903300A (pt)
CA (1) CA2366318A1 (pt)
DE (1) DE60005152T2 (pt)
DK (1) DK1156814T3 (pt)
ES (1) ES2206195T3 (pt)
HK (1) HK1042240B (pt)
PT (1) PT1156814E (pt)
WO (1) WO2000051576A2 (pt)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485752B1 (en) * 2000-10-23 2002-11-26 Otto Torbjorn Hansen Composition and method for alleviating joint pain and stiffness
US6469384B2 (en) * 2001-02-01 2002-10-22 Fairchild Semiconductor Corporation Unmolded package for a semiconductor device
US7025985B2 (en) * 2001-05-28 2006-04-11 Kanebo, Ltd. Dihydroxyphenyl compounds and glucoside compounds thereof
MXPA04003406A (es) * 2001-10-11 2004-06-18 Ct De Investigacion Y Desarrol Procedimiento de obtencion de un extracto de jengibre.
US6811796B2 (en) * 2002-04-22 2004-11-02 Matsuura Yakugyo Co., Ltd. Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
CA2529840A1 (en) * 2003-06-27 2005-01-06 Astellas Pharma Inc. Therapeutic agent for soft tissue sarcoma
US8633246B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
JP2005145900A (ja) * 2003-11-17 2005-06-09 Tsumura & Co 育毛剤組成物及び痒み抑制剤
US7338674B2 (en) * 2004-12-23 2008-03-04 Council Of Scientific And Industrial Research Anti-arthritic herbal composition and method thereof
KR100588469B1 (ko) 2005-02-21 2006-11-23 한국생명공학연구원 생강에서 분리된 쇼가올을 포함하는 비만의 예방 및 치료용조성물
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
US8017162B2 (en) * 2005-10-26 2011-09-13 Oryza Oil & Fat Chemical Co., Ltd. Anti-inflammatory agent
US20090186012A1 (en) * 2005-11-16 2009-07-23 Natbio Pty. Ltd. Plant extract
WO2007066305A1 (en) * 2005-12-09 2007-06-14 Zelpy 2549 (Pty) Limited Compositions comprising sesquiterpene compounds for use in the prophylaxis or treatment of pain
DE102005062144A1 (de) * 2005-12-22 2007-08-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingwerfraktion zur Inhibierung humaner CYP Enzyme
DE102005062145A1 (de) * 2005-12-22 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingwerextrakt zur Inhibierung humaner Arzneistofftransporter
GB2436063A (en) * 2006-03-16 2007-09-19 Nicholas John Larkins Pharmaceutical composition for the treatment of excess mucous production
JP5207341B2 (ja) * 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 炎症性サイトカイン産生抑制剤
US20080160116A1 (en) * 2006-12-07 2008-07-03 Herbalscience Singapore Pte. Ltd Compositions and Methods Comprising Zingiber Species
DE102007055344A1 (de) * 2007-11-19 2009-05-20 K. D. Pharma Bexbach Gmbh Neue Verwendung von Omega-3-Fettsäure(n)
KR20110044968A (ko) * 2008-06-10 2011-05-03 디에스엠 아이피 어셋츠 비.브이. 식물 추출물 및 ｐｕｆａ 조합물
DK2334295T3 (en) 2008-09-02 2017-10-09 Amarin Pharmaceuticals Ie Ltd PHARMACEUTICAL COMPOSITION COMPREHENSIVE EICOSAPENTAIC ACID AND NICOTIC ACID AND PROCEDURES FOR USING SAME
AU2010241567B2 (en) 2009-04-29 2013-10-31 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
WO2010127103A1 (en) 2009-04-29 2010-11-04 Amarin Pharma, Inc. Stable pharmaceutical composition and methods of using same
US8455472B2 (en) 2009-06-15 2013-06-04 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
WO2011035166A1 (en) * 2009-09-18 2011-03-24 Phycoil Biotechnology International, Inc. Microalgae fermentation using controlled illumination
KR101798670B1 (ko) 2009-09-23 2017-11-16 아마린 코포레이션 피엘씨 오메가-3 지방산 및 스타틴의 히드록시-유도체를 포함하는 제약 조성물 및 그의 사용 방법
DE102009055917A1 (de) * 2009-11-27 2011-06-01 Beiersdorf Ag Verwendung von Zingeron gegen Altershaut
NZ587634A (en) * 2010-08-27 2013-10-25 Rato Health Ltd Transdermal Patch
KR101239055B1 (ko) 2010-09-03 2013-03-04 한국식품연구원 제론본 또는 이의 염을 유효성분으로 함유하는 비만예방 및 치료용 조성물
WO2012052848A1 (en) * 2010-10-21 2012-04-26 Innolipid, As Concentration of polyunsaturated fatty acids by distillation using removable isovolatile co-distilling agents
NZ727980A (en) 2010-11-29 2018-08-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
FR2973228B1 (fr) * 2011-04-01 2014-08-01 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
FR2973227B1 (fr) * 2011-04-01 2014-08-08 Oreal Composition cosmetique comprenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one
TWI468170B (zh) 2011-07-18 2015-01-11 Univ Kaohsiung Medical 薑化合物之用途
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
KR101174701B1 (ko) * 2011-12-29 2012-08-17 서울대학교산학협력단 진저레논 에이를 포함하는 비만 예방용 식품 조성물, 비만 치료용 약학조성물 및 비만 치료용 동물용 의약품
EP2800469B1 (en) 2012-01-06 2021-08-25 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
RS61557B1 (sr) 2012-06-29 2021-04-29 Amarin Pharmaceuticals Ie Ltd Postupci za smanjenje rizika od kardiovaskularnog događaja kod pacijenta na terapiji statinom primenom etil estra eikozapentaenske kiseline
WO2014031087A1 (en) * 2012-08-21 2014-02-27 Agricultural Research Develpoment Agency (Public Organization) Natural synergistic formulations containing andrographis paniculata extracts for supporting the inhibition of cartilate degradation in degenerative joint disease
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) * 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
CA2935204A1 (en) * 2013-12-24 2015-07-02 Innovative Herbal Products (Aust) Pty Ltd Treatment of pain
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018041544A1 (en) * 2016-08-30 2018-03-08 Unilever N.V. A personal care composition
US10966951B2 (en) 2017-05-19 2021-04-06 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
WO2020068163A1 (en) 2018-09-24 2020-04-02 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
CN113226058A (zh) * 2019-11-11 2021-08-06 弗门尼舍有限公司 姜酚化合物及其作为风味改良剂的用途
KR20240012390A (ko) 2021-04-21 2024-01-29 애머린 파마슈티칼스 아일랜드 리미티드 심부전의 위험을 감소시키는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01180822A (ja) * 1988-01-12 1989-07-18 Dainippon Pharmaceut Co Ltd 抗遅延型アレルギー剤
JPH07267856A (ja) * 1994-02-09 1995-10-17 Green Cross Corp:The 経口免疫抑制剤
GB9506837D0 (en) * 1995-04-03 1995-05-24 Scotia Holdings Plc Triglycerides
FR2752381B1 (fr) * 1996-08-13 1998-11-06 Pierre Moreau Biotechnologie aviaire, micro nutriments biodisponibles. prevention et traitement de la physiopathologie specifique des maladies de degenerescence et du vieillissement

Also Published As

Publication number Publication date
CA2366318A1 (en) 2000-09-08
DE60005152D1 (de) 2003-10-16
WO2000051576A3 (en) 2001-03-29
ATE249231T1 (de) 2003-09-15
DE60005152T2 (de) 2004-07-08
EP1156814B1 (en) 2003-09-10
US6482421B2 (en) 2002-11-19
US20030035853A1 (en) 2003-02-20
ES2206195T3 (es) 2004-05-16
DK1156814T3 (da) 2004-01-12
HK1042240B (zh) 2004-05-07
US20020051800A1 (en) 2002-05-02
WO2000051576A2 (en) 2000-09-08
HK1042240A1 (en) 2002-08-09
AU2903300A (en) 2000-09-21
EP1156814A2 (en) 2001-11-28
US6638525B2 (en) 2003-10-28

Similar Documents

Publication Publication Date Title
PT1156814E (pt) Compostos farmaceuticos suplementos dieteticos e composicoes cosmeticas compreendendo um acido gordo e gengibre
ATE361066T1 (de) Polyungesättigen fettsäuren nährungsergänzung
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
ATE411032T1 (de) Verwendungen von chitosanoligosacchariden
BR0013958A (pt) Dieta de elevado teor de lipìdios
DE60002581D1 (de) Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz
EA200200019A1 (ru) Композиция, содержащая щелочную сфингомиелиназу, для применения в качестве диетического препарата, пищевой добавки или фармацевтического продукта
US20110142967A1 (en) Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent
JP2006193512A (ja) 外用剤
HUP0304077A2 (hu) A bőr öregedése elleni gyógyászati és kozmetikai készítmények
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
ATE338556T1 (de) Dihydrotriterpene bei der behandlung von virusinfektionen, herz und kreislauf krankheiten, entzündungen, überempfindlichkeiten oder schmerzen
DE50000168D1 (de) Orale darreichungsform
JP2007261946A (ja) アシルアミノ酸亜鉛塩から成る炎症抑制剤
DE502004008870D1 (de) Verwendung omega-3-fettsäurehaltiger öle zur erhöhung der bioverfügbarkeit von pflanzenextrakten
NO20022288D0 (no) Sammensetning til forebygging og/eller behandling av forstyrrelser forårsaket av abnorm lipid metabolisme, sominnbefatter propionyl L-karnitin og kitosan
WO2003002117A3 (en) Niaciamide and derivatives in combination with aminosugar
EP1474998B1 (en) Composition useful for weight control
WO2003097033A3 (fr) Nouvelle compositions neutraceutiques et pharmaceutiques et leurs utilisations
JP2006062968A (ja) むくみ改善剤
KR101229438B1 (ko) 항염증 활성을 갖는 오메가-3 계열 리소포스파티딜콜린 수산화물 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 항염증 조성물
RU92016045A (ru) Биологически активная добавка для косметических изделий
TH48498A3 (th) สารที่คล้ายแคพไซซินอยด์ชนิดใหม่ที่มีพันธะของเอสเตอร์
TH50745C3 (th) สารที่คล้ายแคพไซซินอยด์ชนิดใหม่ที่มีพันธะของเอสเตอร์